Další formáty:
BibTeX
LaTeX
RIS
@article{2299132,
author = {Argyropoulos, Christos and Leckler, Janina and SalmantonandGarcia, Jon and Constantinou, Marinos and Alexandrou, Alexandra and Themistocleous, Sophia and Noula, Evgenia and Shiamakkides, George and Nearchou, Andria and Stewart, Fiona A and Albus, Kerstin and Koniordou, Markela and Kopsidas, Ioannis and Spivak, Orly and Hellemans, Margot and Hendrickx, Greet and Davis, Ruth Joanna and Azzini, Anna Maria and Simon, Paula Valle and CarcasandSansuan, Antonio Javier and Askling, Helena Hervius and Vene, Sirkka and Prellezo, Jana Baranda and alvarezandBarco, Elena and Macken, Alan J and Romina, Di Marzo and Luis, Catarina and Olesen, Ole F and Iniesta, Jesus A Frias and Barta, Imre and Toth, Krisztina and Akova, Murat and Bonten, Marc M J and CohenandKandli, Miriam and Cox, Rebecca Jane and Součková, Lenka and Husa, Petr and Jancoriene, Ligita and Launay, Odile and Lundgren, Jens and Mallon, Patrick and Armeftis, Charis and Marques, Laura and Naucler, Pontus and Ochando, Jordi and Tacconelli, Evelina and Pierre, van Damme and Zaoutis, Theoklis and Hofstraat, Sanne and BruijningandVerhagen, Patricia and Zeitlinger, Markus and Cornely, Oliver A and Pana, Zoi Dorothea},
article_location = {TORONTO},
article_number = {April 2023},
doi = {http://dx.doi.org/10.2196/44491},
keywords = {vaccine trials; volunteer registry; educational material; promotional material; patient education; health communication; health promotion; public health; COVID-19; coronavirus; SARS-CoV-2; pandemic; vaccine; vaccination; hesitancy},
language = {eng},
issn = {2369-2960},
journal = {JMIR PUBLIC HEALTH AND SURVEILLANCE},
title = {Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit},
url = {https://publichealth.jmir.org/2023/1/e44491},
volume = {9},
year = {2023}
}
TY - JOUR
ID - 2299132
AU - Argyropoulos, Christos - Leckler, Janina - Salmanton-Garcia, Jon - Constantinou, Marinos - Alexandrou, Alexandra - Themistocleous, Sophia - Noula, Evgenia - Shiamakkides, George - Nearchou, Andria - Stewart, Fiona A - Albus, Kerstin - Koniordou, Markela - Kopsidas, Ioannis - Spivak, Orly - Hellemans, Margot - Hendrickx, Greet - Davis, Ruth Joanna - Azzini, Anna Maria - Simon, Paula Valle - Carcas-Sansuan, Antonio Javier - Askling, Helena Hervius - Vene, Sirkka - Prellezo, Jana Baranda - alvarez-Barco, Elena - Macken, Alan J - Romina, Di Marzo - Luis, Catarina - Olesen, Ole F - Iniesta, Jesus A Frias - Barta, Imre - Toth, Krisztina - Akova, Murat - Bonten, Marc M J - Cohen-Kandli, Miriam - Cox, Rebecca Jane - Součková, Lenka - Husa, Petr - Jancoriene, Ligita - Launay, Odile - Lundgren, Jens - Mallon, Patrick - Armeftis, Charis - Marques, Laura - Naucler, Pontus - Ochando, Jordi - Tacconelli, Evelina - Pierre, van Damme - Zaoutis, Theoklis - Hofstraat, Sanne - Bruijning-Verhagen, Patricia - Zeitlinger, Markus - Cornely, Oliver A - Pana, Zoi Dorothea
PY - 2023
TI - Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit
JF - JMIR PUBLIC HEALTH AND SURVEILLANCE
VL - 9
IS - April 2023
SP - 1-8
EP - 1-8
PB - JMIR PUBLICATIONS, INC
SN - 23692960
KW - vaccine trials
KW - volunteer registry
KW - educational material
KW - promotional material
KW - patient education
KW - health communication
KW - health promotion
KW - public health
KW - COVID-19
KW - coronavirus
KW - SARS-CoV-2
KW - pandemic
KW - vaccine
KW - vaccination
KW - hesitancy
UR - https://publichealth.jmir.org/2023/1/e44491
N2 - Background: The pan-European VACCELERATE network aims to implement the first transnational harmonized and sustainable vaccine trial Volunteer Registry, being a single entry point for potential volunteers of large-scale vaccine trials across Europe. This work exhibits a set of harmonized vaccine trial-related educational and promotional tools for the general public, designed and disseminated by the pan-European VACCELERATE network. Objective: This study primarily aimed to design and develop a standard toolkit to increase positive attitudes and access to trustworthy information for better access and increased recruitment to vaccine trials for the public. More specifically, the produced tools are focused on inclusiveness and equity, and are targeting different population groups, including underserved ones, as potential volunteers for the VACCELERATE Volunteer Registry (older individuals, migrants, children, and adolescents). The promotional and educational material is aligned with the main objectives of the Volunteer Registry to increase public literacy and awareness regarding vaccine-related clinical research or trials and trial participation, including informed consent and legal issues, side effects, and frequently asked questions regarding vaccine trial design.Methods: Tools were developed per the aims and principles of the VACCELERATE project, focusing on trial inclusiveness and equity, and are adjusted to local country-wise requirements to improve public health communication. The produced tools are selected based on the cognitive theory, inclusiveness, and equity of differently aged and underrepresented groups, and standardized material from several official trustworthy sources (eg, COVID-19 Vaccines Global Access; the European Centre for Disease Prevention and Control; the European Patients' Academy on Therapeutic Innovation; Gavi, the Vaccine Alliance; and the World Health Organization). A team of multidisciplinary specialists (infectious diseases, vaccine research, medicine, and education) edited and reviewed the subtitles and scripts of the educational videos, extended brochures, interactive cards, and puzzles. Graphic designers selected the color palette, audio settings, and dubbing for the video story-tales and implemented QR codes.Results: This study presents the first set of harmonized promotional and educational materials and tools (ie, educational cards, educational and promotional videos, extended brochures, flyers, posters, and puzzles) for vaccine clinical research (eg, COVID-19 vaccines). These tools inform the public about possible benefits and disadvantages of trial participation and build confidence among participants about the safety and efficacy of COVID-19 vaccines and the health care system. This material has been translated into several languages and is intended to be freely and easily accessible to facilitate dissemination among VACCELERATE network participant countries and the European and global scientific, industrial, and public community.Conclusions: The produced material could help fill knowledge gaps of health care personnel, providing the appropriate future patient education for vaccine trials, and tackling vaccine hesitancy and parents' concerns for potential participation of children in vaccine trials.
ER -
ARGYROPOULOS, Christos, Janina LECKLER, Jon SALMANTON-GARCIA, Marinos CONSTANTINOU, Alexandra ALEXANDROU, Sophia THEMISTOCLEOUS, Evgenia NOULA, George SHIAMAKKIDES, Andria NEARCHOU, Fiona A STEWART, Kerstin ALBUS, Markela KONIORDOU, Ioannis KOPSIDAS, Orly SPIVAK, Margot HELLEMANS, Greet HENDRICKX, Ruth Joanna DAVIS, Anna Maria AZZINI, Paula Valle SIMON, Antonio Javier CARCAS-SANSUAN, Helena Hervius ASKLING, Sirkka VENE, Jana Baranda PRELLEZO, Elena ALVAREZ-BARCO, Alan J MACKEN, Di Marzo ROMINA, Catarina LUIS, Ole F OLESEN, Jesus A Frias INIESTA, Imre BARTA, Krisztina TOTH, Murat AKOVA, Marc M J BONTEN, Miriam COHEN-KANDLI, Rebecca Jane COX, Lenka SOUČKOVÁ, Petr HUSA, Ligita JANCORIENE, Odile LAUNAY, Jens LUNDGREN, Patrick MALLON, Charis ARMEFTIS, Laura MARQUES, Pontus NAUCLER, Jordi OCHANDO, Evelina TACCONELLI, van Damme PIERRE, Theoklis ZAOUTIS, Sanne HOFSTRAAT, Patricia BRUIJNING-VERHAGEN, Markus ZEITLINGER, Oliver A CORNELY a Zoi Dorothea PANA. Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit. \textit{JMIR PUBLIC HEALTH AND SURVEILLANCE}. TORONTO: JMIR PUBLICATIONS, INC, 2023, roč.~9, April 2023, s.~1-8. ISSN~2369-2960. Dostupné z: https://dx.doi.org/10.2196/44491.
|
